Benzinga's Top Pre-Market Losers

Impax Laboratories (NASDAQ: IPXL ) dipped 21.00% to $15.80 in the pre-market session. Impax Laboratories reported that the FDA completed its re-inspection of its Hayward manufacturing facility. At the conclusion of this inspection, the FDA issued a new Form 483 with 12 observations. Hospira (NYSE: HSP ) shares dropped